Search filters

List of works by Arne Ring

A Phase I study to determine the pharmacokinetic profile, safety and tolerability of sildenafil (Revatio® ) in cardiac surgery: the REVAKI-1 study

scientific article

A Randomized, Open-Label, Crossover Study Evaluating the Effect of Food on the Relative Bioavailability of Linagliptin in Healthy Subjects ⬇️

scientific article published on July 30, 2011

A randomised controlled trial of six weeks of home enteral nutrition versus standard care after oesophagectomy or total gastrectomy for cancer: report on a pilot and feasibility study

scientific article

Assessment of the pharmacokinetic interaction between the novel DPP-4 inhibitor linagliptin and a sulfonylurea, glyburide, in healthy subjects

scientific article published on 12 November 2010

Bioequivalence of Linagliptin 5 mg once daily and 2.5 mg twice daily: pharmacokinetics and pharmacodynamics in an open-label crossover trial.

scientific article published on 23 October 2013

Cluster randomised trial of a tailored intervention to improve the management of overweight and obesity in primary care in England

scientific article published on 27 May 2016

Complete Versus Lesion-Only Primary PCI: The Randomized Cardiovascular MR CvLPRIT Substudy

scientific article

Dabigatran does not prolong the QT interval with supratherapeutic exposure: a thorough QT study in healthy subjects.

scientific article published on May 2013

Delayed Effects in the Exposure-Response Analysis of Clinical QTc Trials ⬇️

scientific article published on January 1, 2012

Effect of food and tablet-dissolution characteristics on the bioavailability of linagliptin fixed-dose combination with metformin: evidence from two randomized trials.

scientific article published on July 2014

Effect of linagliptin on the pharmacokinetics and pharmacodynamics of warfarin in healthy volunteers

scientific article published on 01 May 2011

Effect of multiple oral doses of linagliptin on the steady-state pharmacokinetics of a combination oral contraceptive in healthy female adults: an open-label, two-period, fixed-sequence, multiple-dose study.

scientific article published in January 2011

Effect of renal impairment on the pharmacokinetics of the dipeptidyl peptidase-4 inhibitor linagliptin(*)

scientific article published on 01 October 2011

Evaluation of a self-administered oral glucose tolerance test

scientific article published on 15 January 2013

Evaluation of a tailored intervention to improve management of overweight and obesity in primary care: study protocol of a cluster randomised controlled trial.

scientific article published on 19 March 2014

Evaluation of the pharmacokinetic interaction after multiple oral doses of linagliptin and digoxin in healthy volunteers

scientific article published on 22 February 2011

Evaluation of the potential for steady-state pharmacokinetic and pharmacodynamic interactions between the DPP-4 inhibitor linagliptin and metformin in healthy subjects.

scientific article published in August 2009

How publication guidelines for clinical pharmacology trials may help to accelerate knowledge transfer.

scientific article published on 9 February 2018

Ibuprofen extrudate, a novel, rapidly dissolving ibuprofen formulation: relative bioavailability compared to ibuprofen lysinate and regular ibuprofen, and food effect on all formulations.

scientific article published in September 2005

Indirect bioequivalence assessment using network meta-analyses.

scientific article published on 20 May 2014

Infarct size following complete revascularization in patients presenting with STEMI: a comparison of immediate and staged in-hospital non-infarct related artery PCI subgroups in the CvLPRIT study. ⬇️

scientific article

Interpretation of general measures of distribution kinetics in terms of a mammillary compartmental model.

scientific article published in December 1997

Linagliptin (BI 1356), a potent and selective DPP-4 inhibitor, is safe and efficacious in combination with metformin in patients with inadequately controlled Type 2 diabetes.

scientific article published on December 2010

Linagliptin fixed-dose combination with metformin is bioequivalent to co-administration of linagliptin and metformin as individual tablets

scientific article published on 01 July 2014

Mixed models for data from thorough QT studies: part 1. assessment of marginal QT prolongation.

scientific article

Pharmacokinetics and Pharmacodynamics of Single Rising Intravenous Doses (0.5 mg–10 mg) and Determination of Absolute Bioavailability of the Dipeptidyl Peptidase-4 Inhibitor Linagliptin (BI 1356) in Healthy Male Subjects

scientific article published on December 1, 2010

Pharmacokinetics of linagliptin in subjects with hepatic impairment

scientific article

Pharmacokinetics of single and multiple oral doses of 5 mg linagliptin in healthy Chinese volunteers

scientific article published on December 1, 2012

Rationale, design, and organization of a randomized, controlled Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS) in patients with type 2 diabetes and established cardiovascular disease.

scientific article published on 23 October 2013

Sample size determination in bioequivalence studies using statistical assurance

scientific article published on 13 August 2019

Sensitivity of empirical metrics of rate of absorption in bioequivalence studies

scientific article published on 01 May 2000

Statistical reporting of clinical pharmacology research.

scientific article

The DPP‐4 inhibitor linagliptin does not prolong the QT interval at therapeutic and supratherapeutic doses ⬇️

scientific article published on July 1, 2011

The oral DPP-4 inhibitor linagliptin significantly lowers HbA1c after 4 weeks of treatment in patients with type 2 diabetes mellitus

scientific article published on 01 June 2011

The potential of the estimands framework for clinical pharmacology trials: Some discussion points

scientific article published on 06 February 2020

The randomised Complete versus Lesion-only PRimary percutaneous coronary Intervention Trial: Cardiovascular Magnetic Resonance imaging substudy (CvLPRIT-CMR)

scientific article

The sodium glucose cotransporter 2 inhibitor empagliflozin does not prolong QT interval in a thorough QT (TQT) study ⬇️

scientific article published on April 24, 2013

Trial protocol for a randomised controlled trial of red cell washing for the attenuation of transfusion-associated organ injury in cardiac surgery: the REDWASH trial

scientific article published on 7 March 2016

Paulina is supported by:

About Paulina

Help